Healthcare

Request for TOC Request for Sample
BUY NOW

Europe Urology Laser Market – Industry Trends and Forecast to 2030

Healthcare | Published Report | May 2023 | Europe | 350 Pages | No of Tables: 39 | No of Figures: 40

Report Description

Europe Urology Laser Market, By Laser Type (Holmium Yttrium Aluminum Garnet (Ho:Yag), Thulium Yttrium Aluminum Garnet (Thu:Yag),  Neodymium-Doped Yttrium Aluminum Garnet (Nd:Yag), Potassium Titanyl Phosphate Yttrium Aluminum Garnet (Ktp:Yag), Diode Laser, Erbium: Yttrium Aluminum Garnet Laser, Lithium Borate, and Others), Modality (Portable and Standalone), Application (Urolithiasis, Benign Prostatic Hyperplasia (BPH), Partial Kidney Resection, Removal of Kidney Stones, Urethral Strictures, Tumors, and Others), End User (Hospitals, Urological Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retails Sales, Online Sales, and Others) - Industry Trends and Forecast to 2030.


Europe Urology Laser Market Analysis and Insights

The Europe urology laser market is expected to develop due to the rising number of patients related to urology disorders Europe and an increased inclination towards non-invasive surgeries. The increase in product approval and research and development actives for urology laser devices also influence the market. However, the Europe urology laser market is expected to be hampered by the high cost of urology laser devices and procedures, safety concerns and adverse effects associated with laser procedures, and a lack of awareness about the treatment from laser devices.


Get Exclusive Sample Copy of this Report Here

Additional technological advancements in laser technology and strategic initiatives by emerging players are expected to act as opportunities for market growth. However, stringent regulations and a lack of skilled professionals challenge market growth.

The demand for the urology laser market has increased in both developed and developing countries, and the reason behind this is the efficient laser tissue interaction delivered by these systems. Thus, many market players are offering urology laser products with innovations that pave the way for the growth of the Europe urology laser market.

Data Bridge Market Research analyzes that the Europe urology laser market will grow at a CAGR of 5.2% from 2023 to 2030.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable 2016- 2020)

Quantitative Units

Revenue in Thousand, Volumes in Units, Pricing in USD

Segments Covered

Laser Type (Holmium Yttrium Aluminum Garnet (Ho:Yag), Thulium Yttrium Aluminum Garnet (Thu:Yag),  Neodymium-Doped Yttrium Aluminum Garnet (Nd:Yag), Potassium Titanyl Phosphate Yttrium Aluminum Garnet (Ktp:Yag), Diode Laser, Erbium: Yttrium Aluminum Garnet Laser, Lithium Borate, and Others), Modality (Portable and Standalone), Application (Urolithiasis, Benign Prostatic Hyperplasia (BPH), Partial Kidney Resection, Removal of Kidney Stones, Urethral Strictures, Tumors, and Others), End User (Hospitals, Urological Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retails Sales, Online Sales, and Others)

Countries Covered

Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, and rest of Europe

Market Players Covered

BD, Richard Wolf GmbH., Olympus Corporation, Coherent, Inc., Rocamed, Dornier MedTech, Limmer Laser GmbH, Gigaalaser, Boston Scientific Corporation, Cook, OmniGuide Holdings, Inc., and Allengers among others.

Market Definition

Laser technology is based on the ability of a device to emit a narrow beam of highly focused light. The laser medium defines the wavelength in each LASER (Light Amplification by Stimulated Emission of Radiation) system. Parallel radiation from the device makes it easy to focus on a target due to its small focus and high intensity. Urology lasers are the medical devices or components used to excision tumors in the urethra, bladder, ureter, and kidneys. Urology lasers emit a tiny beam of light, offering an accurate, precise, and painless surgical treatment.

Currently, the most commonly used lasers in urology are Ktp:Yag (Potassium titanyl phosphate), Lbo:Yag (lithium borate), diode lasers, Holmium (Ho):Yag, and Thulium (Tm):Yag lasers.

Europe Urology Laser Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • Rising Number of Patients Related to Urology Disorders Europe

Urological conditions affect people of various age groups and are among the most common clinical conditions in geriatric patients. The incidence and prevalence of many urologic conditions increase with passing age. The senior population is increasing rapidly compared to other age groups. As population demographics continue to shift, there will be an increasing need for urologic practitioners with expertise in geriatrics and aging. The conditions may lead to disability and impaired quality of life. The common urological conditions are urinary continence, urolithiasis, urological cancer, and prostate cancer.

Increasing cases of urology disorders have positively impacted the demand for laser devices. Thus, the rising number of patient-related with urology disorders is expected to drive market growth in the forecast period.

  • Rising Research and Development Activities for Urology Laser Devices

Research & development is crucial in all industries, including the healthcare industry. The healthcare industry conducts extensive research and development to generate revenue, often resulting in lives by saving or enhancing a patient's life.

Research and development (R&D) is a prerequisite opportunity for market players to discover new techniques for developing urology lasers. The market players focus on creating urology lasers to fulfill unmet medical needs.

In recent years, laser techniques have become an increasingly popular treatment method for patients with benign prostatic hyperplasia, bladder tumors, urolithiasis, urinary tract strictures, or lesions of the external genitalia, which increase research and development of urology laser devices. Hence, R&D collaborates with market players to invest in expected costs for novel urological laser devices in the forecast period.

Opportunity

  • Technological Advancements in Laser Technology

Technological advancement is considered the major driver for the urology laser market. Urology laser is convenient and effective for treating prostatic hyperplasia, bladder tumors, and urolithiasis.

Thus, the urology laser holds major importance in the treatment market. Furthermore, it is also used to inspect and treat cysts, tumors, or abnormal tissues in the urinary system. The key market players have made new advancements in the laser market to meet the desired disease treatment needs.

During early history, the understanding of urology and diseases swiftly expanded. While primitive urologists propagated the idea of using urine as a therapeutic substance, modern urologists found the idea of removing a kidney remotely by applying technological developments such as next-generation MOSES 2.0 Holmium laser technology.

The surge in technological applications for urology laser devices would result in less workforce, swift treatment, and recovery of urological diseases. In the future, the laser technique will replace manual urology devices. Laser devices reduce the use of surgical instruments. Thus it is expected to act as an opportunity for market growth in the forecast period.

  • Strategic Initiatives by Emerging Players  

The major players are trying to devise specific strategies, such as product launches, acquisitions, approvals, expansions, and partnerships, to ensure the smooth running of the business, avoid risks, and increase the long-term growth in the sales of the market. This proportionally helps to increase consumer demand for products and thus increases sales in the future.

Urology laser device demand is increasing due to technological advances and the increasing incidence of urology disorders worldwide. The top market players have implemented certain programs aimed at increasing the operation and profitability of the urology laser market. The companies have adopted specific strategies such as acquisitions, partnerships, product orders, and other methods to create opportunities in the international market for urology laser devices.

These strategic initiatives by the market players, including acquisition, conferences, and focused segment product launches, are helping the companies grow and improve the company's product portfolio, ultimately leading to more revenue generation. Hence, these strategic initiatives by the market players provide an opportunity to drive market growth in the forecast period.

Restraint/Challenge

  • High Cost of Urology Laser Device and Procedure

Urology laser devices can be expensive to manufacture and purchase, and the procedure cost can also be high due to the specialized equipment and training required. This can limit the accessibility of urology laser treatments for patients and healthcare facilities, particularly in lower-income regions. Additionally, the high cost of urology laser devices and procedures may deter some patients from choosing these treatments, especially if they have to pay out of pocket. Insurance coverage for urology laser treatments can also be limited, limiting their adoption.

As a result, the high cost of urology laser devices and procedures can be a significant barrier to the growth of the Europe urology laser market, especially in regions where cost is a major factor. However, as technology advances, the cost of these devices and procedures may decrease, making them more accessible to patients and healthcare facilities.

The increased intricacy of urology laser devices and the high cost of urology laser treatment is expected to restrain the market growth in the forecast period.

Recent Development

  • In May 2022, OmniGuide Holdings announced that the U.S. Food and Drug Administration cleared its upcoming product RevoLix HTL a family of pulsed and continuous wave Thulium YAG lasers, therefore a foundation of RevoLix Therapy for urology patients undergoing BPH and Stone Management procedures With the FDA's clearance of a standalone reader, the company will have expected to generate more revenue.

Europe Urology Laser Market Scope

The urology laser market is categorized into five notable segments, which are laser type, modality, application, end user, and distribution channel. The growth amongst these segments will help you analyze market growth segments in the industries and provide the user with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Laser Type

  • Holmium Yttrium Aluminum Garnet (Ho:Yag)
  •  Thulium Yttrium Aluminum Garnet (Thu:Yag)
  •  Neodymium-Doped Yttrium Aluminum Garnet (Nd:Yag)
  •  Potassium Titanyl Phosphate Yttrium Aluminum Garnet (Ktp:Yag)
  •  Diode Laser
  •  Erbium: Yttrium Aluminum Garnet Laser
  •  Lithium Borate
  •  Others

On the basis of laser type, the urology laser market is segmented into holmium yttrium aluminum garnet (Ho:Yag), thulium yttrium aluminum garnet (Thu:Yag),  neodymium-doped yttrium aluminum garnet (Nd:Yag), potassium titanyl phosphate yttrium aluminum garnet (Ktp:Yag), diode laser, erbium: yttrium aluminum garnet laser, lithium borate, and others.

Modality

  • Portable
  • Standalone

On the basis modality, the urology laser market is segmented into standalone and portable.

Application

  • Urolithiasis
  • Benign Prostatic Hyperplasia (BPH)
  • Partial Kidney Resection
  • Removal of  Kidney Stones
  • Urethral Strictures
  • Tumors
  • Others

On the basis of application, the urology laser market is segmented into urolithiasis, benign prostatic hyperplasia (BPH), partial kidney resection, removal of kidney stones, urethral strictures, tumors, and others.

End User

  • Hospitals
  • Urological Clinics

  • Ambulatory Surgical Centers
  • Others

On the basis of end user, the urology laser market is segmented into hospitals, urological clinics, ambulatory surgical centers, and others.

Distribution Channel

  • Direct Tender
  •  Retail Sales
  •  Online Sales
  •  Others

On the basis of distribution channel, the urology laser market is segmented into direct tender retail sales, online sales, and others.


Europe Urology Laser Market Regional Analysis/Insights

The Europe urology laser market is analyzed, and market size insights and trends are provided based on type, modality, application, end user, and distribution channel.

The countries covered in this market report are Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, and rest of Europe.

Germany is expected to dominate Europe due to the increasing technology and reliability of healthcare services. The demand in this region is projected to be driven by a rise in urology diseases with the growing integration of healthcare data with portable devices.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges due to large or scarce competition from local and domestic brands and the impact of domestic tariffs and trade routes are considered while providing a forecast analysis of the country data.

Competitive Landscape and Europe Urology Laser Market Share Analysis

The urology laser market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies' focus related to the market.

Some of the major players in the Europe urology laser market are BD, Richard Wolf GmbH., Olympus Corporation, Coherent, Inc., Rocamed, Dornier MedTech, Limmer Laser GmbH, Gigaalaser, Boston Scientific Corporation, Cook, OmniGuide Holdings, Inc., and Allengers among others.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE UROLOGY LASER MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 IMPORT-EXPORT ANALYSIS

4.3.1 IMPORT

4.3.2 EXPORT

4.4 STRATEGIC INITIATIVES

4.5 PRICING ANALYSIS

4.6 ADOPTION OF LASER

5 EUROPE UROLOGY LASER MARKET, EPIDEMIOLOGY

5.1 INCIDENCE AND PREVALENCE OF UROLOGY DISORDERS, BY COUNTRY

5.2 UROLITHIASIS

5.3 BENIGN PROSTATIC HYPERPLASIA (BPH)

5.4 PARTIAL KIDNEY RESECTION

5.5 KIDNEY STONES

5.6 URETHRAL STRICTURES

5.7 TUMORS

6 EUROPE UROLOGY LASER MARKET, REGULATIONS

6.1 REGULATORY SCENARIO IN THE U.S.

6.2 REGULATORY SCENARIO IN AUSTRALIA

6.3 REGULATORY SCENARIO IN INDIA

6.4 REGULATORY SCENARIO IN U.K.

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISING NUMBER OF PATIENTS RELATED TO UROLOGY DISORDERS EUROPELY

7.1.2 INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES

7.1.3 RISE IN THE NUMBER OF PRODUCT APPROVAL FOR LASER DEVICES

7.1.4 RISING RESEARCH AND DEVELOPMENT ACTIVITIES FOR UROLOGY LASER DEVICES

7.2 RESTRAINTS

7.2.1 HIGH COST OF UROLOGY LASER DEVICE AND PROCEDURE

7.2.2 SAFETY CONCERNS AND ADVERSE EFFECTS ASSOCIATED WITH LASER PROCEDURES SAFETY CONCERNS

7.2.3 LACK OF AWARENESS ABOUT TREATMENT FOR UROLOGICAL CONDITIONS

7.3 OPPORTUNITIES

7.3.1 TECHNOLOGICAL ADVANCEMENTS IN LASER TECHNOLOGY

7.3.2 STRATEGIC INITIATIVES BY EMERGING PLAYERS

7.4 CHALLENGES

7.4.1 LACK OF SKILLED PROFESSIONALS

7.4.2 STRINGENT REGULATIONS

8 EUROPE UROLOGY LASER MARKET, BY LASER TYPE

8.1 OVERVIEW

8.2 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)

8.3 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)

8.4 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)

8.5 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)

8.6 DIODE LASER

8.7 ERBIUM: YTTRIUM ALUMINUM GARNET LASER

8.8 LITHIUM BORATE

8.9 OTHERS

9 EUROPE UROLOGY LASER MARKET, BY MODALITY

9.1 OVERVIEW

9.2 PORTABLE

9.3 STANDALONE

10 EUROPE UROLOGY LASER MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 UROLITHIASIS

10.2.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)

10.2.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)

10.2.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)

10.2.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)

10.2.5 DIODE LASER

10.2.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER

10.2.7 LITHIUM BORATE

10.2.8 OTHERS

10.3 BENIGN PROSTATIC HYPERPLASIA (BPH)

10.3.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)

10.3.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)

10.3.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)

10.3.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)

10.3.5 DIODE LASER

10.3.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER

10.3.7 LITHIUM BORATE

10.3.8 OTHERS

10.4 PARTIAL KIDNEY RESECTION

10.4.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)

10.4.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)

10.4.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)

10.4.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)

10.4.5 DIODE LASER

10.4.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER

10.4.7 LITHIUM BORATE

10.4.8 OTHERS

10.5 REMOVAL OF KIDNEY STONES

10.5.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)

10.5.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)

10.5.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)

10.5.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)

10.5.5 DIODE LASER

10.5.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER

10.5.7 LITHIUM BORATE

10.5.8 OTHERS

10.6 URETHRAL STRICTURES

10.6.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)

10.6.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)

10.6.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)

10.6.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)

10.6.5 DIODE LASER

10.6.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER

10.6.7 LITHIUM BORATE

10.6.8 OTHERS

10.7 TUMORS

10.7.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)

10.7.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)

10.7.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)

10.7.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)

10.7.5 DIODE LASER

10.7.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER

10.7.7 LITHIUM BORATE

10.7.8 OTHERS

10.8 OTHERS

10.8.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)

10.8.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)

10.8.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)

10.8.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)

10.8.5 DIODE LASER

10.8.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER

10.8.7 LITHIUM BORATE

10.8.8 OTHERS

11 EUROPE UROLOGY LASER MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITALS

11.3 UROLOGICAL CLINICS

11.4 AMBULATORY SURGICAL CENTERS

11.5 OTHERS

12 EUROPE UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL SALES

12.4 ONLINE SALES

12.5 OTHERS

13 EUROPE UROLOGY LASER MARKET, BY REGION

13.1 EUROPE

13.1.1 GERMANY

13.1.2 U.K.

13.1.3 ITALY

13.1.4 FRANCE

13.1.5 SPAIN

13.1.6 RUSSIA

13.1.7 SWITZERLAND

13.1.8 TURKEY

13.1.9 BELGIUM

13.1.10 NETHERLANDS

13.1.11 REST OF EUROPE

14 EUROPE UROLOGY LASER MARKET, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 BOSTON SCIENTIFIC CORPORATION

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 COOK

16.2.1 COMPANY SNAPSHOT

16.2.2 COMPANY SHARE ANALYSIS

16.2.3 PRODUCT PORTFOLIO

16.2.4 RECENT DEVELOPMENT

16.3 OLYMPUS CORPORATION

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENT

16.4 COHERENT, INC.

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 DORNIER MEDTECH

16.5.1 COMPANY SNAPSHOT

16.5.2 COMPANY SHARE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENT

16.6 ADVIN HEALTH CARE

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 ALLENGERS

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

16.8 BD

16.8.1 COMPANY SNAPSHOT

16.8.2 REVENUE ANALYSIS

16.8.3 PRODUCT PORTFOLIO

16.8.4 RECENT DEVELOPMENTS

16.9 BIOLITEC AG

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 BISON MEDICAL

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 CONVERGENT LASER TECHNOLOGIES

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 EMS UROLOGY

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENTS

16.13 GIGAALASER

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 HEALTHWARE PVT LTD.

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 HYPERPHOTONICS.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 INTERMEDIC ARFRAN

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENT

16.17 LIMMER LASER GMBH

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 MONOCROM

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENT

16.19 OMNIGUIDE HOLDINGS, INC.

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 POTENT MEDICAL.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENT

16.21 QUANTA SYSTEM

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 RICHARD WOLF GMBH.

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENTS

16.23 ROCAMED

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENTS

16.24 SURGICAL LASERS INC.

16.24.1 COMPANY SNAPSHOT

16.24.2 PRODUCT PORTFOLIO

16.24.3 RECENT DEVELOPMENT

16.25 TRIMEDYNE, INC.

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.25.3 RECENT DEVELOPMENT

16.26 UNIQUE MEDICAL DEVICES

16.26.1 COMPANY SNAPSHOT

16.26.2 PRODUCT PORTFOLIO

16.26.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 IN 2022, ACCORDING TO THE ARTICLE PUBLISHED BY ELSEVIER LTD, THE FOLLOWING WAS THE DATA ON THE PREVALENCE AND INCIDENT RATES OF BPH IN 2019

TABLE 2 FOLLOWING TABLES SHOW TOTAL EUROPE KIDNEY CANCER INCIDENCE AND RATES IN 2020 FOR COUNTRIES WITH THE HIGHEST RATES OF KIDNEY CANCER/TUMORS.

TABLE 3 EUROPE UROLOGY LASER MARKET, BY LASER TYPE, 2021-2030 (USD THOUSAND)

TABLE 4 EUROPE HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 5 EUROPE THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 6 EUROPE NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 7 EUROPE POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 8 EUROPE DIODE LASER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 9 EUROPE ERBIUM: YTTRIUM ALUMINUM GARNET LASER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 10 EUROPE LITHIUM BORATE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 11 EUROPE OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 12 EUROPE UROLOGY LASER MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)

TABLE 13 EUROPE PORTABLE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 14 EUROPE STANDALONE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 15 EUROPE UROLOGY LASER MARKET, BY APPLICATION 2021-2030 (USD THOUSAND)

TABLE 16 EUROPE UROLITHIASIS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 17 EUROPE UROLITHIASIS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 18 EUROPE BENIGN PROSTATIC HYPERPLASIA (BPH) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 19 EUROPE BENIGN PROSTATIC HYPERPLASIA (BPH) IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 20 EUROPE PARTIAL KIDNEY RESECTION IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 21 EUROPE PARTIAL KIDNEY RESECTION IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 22 EUROPE REMOVAL OF KIDNEY STONES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 23 EUROPE REMOVAL OF KIDNEY STONES IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 24 EUROPE URETHRAL STRICTURES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 25 EUROPE URETHRAL STRICTURES IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 26 EUROPE TUMORS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 27 EUROPE TUMORS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 28 EUROPE OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 29 EUROPE OTHERS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 30 EUROPE UROLOGY LASER MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 31 EUROPE HOSPITALS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 32 EUROPE UROLOGICAL CLINICS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 33 EUROPE AMBULATORY SURGICAL CENTERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 34 EUROPE OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 35 EUROPE UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 36 EUROPE DIRECT TENDER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 37 EUROPE RETAIL SALES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 38 EUROPE ONLINE SALES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 39 EUROPE OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)

List of Figure

FIGURE 1 EUROPE UROLOGY LASER MARKET: SEGMENTATION

FIGURE 2 EUROPE UROLOGY LASER MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE UROLOGY LASER MARKET: DROC ANALYSIS

FIGURE 4 EUROPE UROLOGY LASER MARKET: EUROPE VS. REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE UROLOGY LASER MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE UROLOGY LASER MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE UROLOGY LASER MARKET: MULTIVARIATE MODELLING

FIGURE 8 EUROPE UROLOGY LASER MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE UROLOGY LASER MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE UROLOGY LASER MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 EUROPE UROLOGY LASER MARKET: SEGMENTATION

FIGURE 12 RISING NUMBER OF PATIENT RELATED TO UROLOGY DISORDER AND I INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES IS EXPECTED TO DRIVE THE EUROPE UROLOGY LASER MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 13 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE UROLOGY LASER MARKET IN 2023 & 2030

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE UROLOGY LASER MARKET

FIGURE 15 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, 2022

FIGURE 16 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, 2023-2030 (USD THOUSAND)

FIGURE 17 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, CAGR (2023-2030)

FIGURE 18 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, LIFELINE CURVE

FIGURE 19 EUROPE UROLOGY LASER MARKET: BY MODALITY, 2022

FIGURE 20 EUROPE UROLOGY LASER MARKET: BY MODALITY, 2023-2030 (USD THOUSAND)

FIGURE 21 EUROPE UROLOGY LASER MARKET: BY MODALITY, CAGR (2023-2030)

FIGURE 22 EUROPE UROLOGY LASER MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 23 EUROPE UROLOGY LASER MARKET: BY APPLICATION, 2022

FIGURE 24 EUROPE UROLOGY LASER MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)

FIGURE 25 EUROPE UROLOGY LASER MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 26 EUROPE UROLOGY LASER MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 27 EUROPE UROLOGY LASER MARKET: BY END USER, 2022

FIGURE 28 EUROPE UROLOGY LASER MARKET: BY END USER, 2023-2030 (USD THOUSAND)

FIGURE 29 EUROPE UROLOGY LASER MARKET: BY END USER, CAGR (2023-2030)

FIGURE 30 EUROPE UROLOGY LASER MARKET: BY END USER, LIFELINE CURVE

FIGURE 31 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 32 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)

FIGURE 33 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 34 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 35 EUROPE UROLOGY LASER MARKET: SNAPSHOT (2022)

FIGURE 36 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2022)

FIGURE 37 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2023 & 2030)

FIGURE 38 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2022 & 2030)

FIGURE 39 EUROPE UROLOGY LASER MARKET: BY LASER TYPE (2023-2030)

FIGURE 40 EUROPE UROLOGY LASER MARKET: COMPANY SHARE 2022 (%)

View Infographics

FIGURE 1 EUROPE UROLOGY LASER MARKET: SEGMENTATION

FIGURE 2 EUROPE UROLOGY LASER MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE UROLOGY LASER MARKET: DROC ANALYSIS

FIGURE 4 EUROPE UROLOGY LASER MARKET: EUROPE VS. REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE UROLOGY LASER MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE UROLOGY LASER MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE UROLOGY LASER MARKET: MULTIVARIATE MODELLING

FIGURE 8 EUROPE UROLOGY LASER MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE UROLOGY LASER MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE UROLOGY LASER MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 EUROPE UROLOGY LASER MARKET: SEGMENTATION

FIGURE 12 RISING NUMBER OF PATIENT RELATED TO UROLOGY DISORDER AND I INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES IS EXPECTED TO DRIVE THE EUROPE UROLOGY LASER MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 13 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE UROLOGY LASER MARKET IN 2023 & 2030

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE UROLOGY LASER MARKET

FIGURE 15 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, 2022

FIGURE 16 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, 2023-2030 (USD THOUSAND)

FIGURE 17 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, CAGR (2023-2030)

FIGURE 18 EUROPE UROLOGY LASER MARKET: BY LASER TYPE, LIFELINE CURVE

FIGURE 19 EUROPE UROLOGY LASER MARKET: BY MODALITY, 2022

FIGURE 20 EUROPE UROLOGY LASER MARKET: BY MODALITY, 2023-2030 (USD THOUSAND)

FIGURE 21 EUROPE UROLOGY LASER MARKET: BY MODALITY, CAGR (2023-2030)

FIGURE 22 EUROPE UROLOGY LASER MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 23 EUROPE UROLOGY LASER MARKET: BY APPLICATION, 2022

FIGURE 24 EUROPE UROLOGY LASER MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)

FIGURE 25 EUROPE UROLOGY LASER MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 26 EUROPE UROLOGY LASER MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 27 EUROPE UROLOGY LASER MARKET: BY END USER, 2022

FIGURE 28 EUROPE UROLOGY LASER MARKET: BY END USER, 2023-2030 (USD THOUSAND)

FIGURE 29 EUROPE UROLOGY LASER MARKET: BY END USER, CAGR (2023-2030)

FIGURE 30 EUROPE UROLOGY LASER MARKET: BY END USER, LIFELINE CURVE

FIGURE 31 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 32 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)

FIGURE 33 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 34 EUROPE UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 35 EUROPE UROLOGY LASER MARKET: SNAPSHOT (2022)

FIGURE 36 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2022)

FIGURE 37 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2023 & 2030)

FIGURE 38 EUROPE UROLOGY LASER MARKET: BY COUNTRY (2022 & 2030)

FIGURE 39 EUROPE UROLOGY LASER MARKET: BY LASER TYPE (2023-2030)

FIGURE 40 EUROPE UROLOGY LASER MARKET: COMPANY SHARE 2022 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19